147 related articles for article (PubMed ID: 28333964)
1. Optimizing ultrasound molecular imaging of secreted frizzled related protein 2 expression in angiosarcoma.
Tsuruta JK; Schaub NP; Rojas JD; Streeter J; Klauber-DeMore N; Dayton P
PLoS One; 2017; 12(3):e0174281. PubMed ID: 28333964
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound molecular imaging of secreted frizzled related protein-2 expression in murine angiosarcoma.
Tsuruta JK; Klauber-DeMore N; Streeter J; Samples J; Patterson C; Mumper RJ; Ketelsen D; Dayton P
PLoS One; 2014; 9(1):e86642. PubMed ID: 24489757
[TBL] [Abstract][Full Text] [Related]
3. A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature.
Warram JM; Sorace AG; Saini R; Umphrey HR; Zinn KR; Hoyt K
J Ultrasound Med; 2011 Jul; 30(7):921-31. PubMed ID: 21705725
[TBL] [Abstract][Full Text] [Related]
4. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice.
Willmann JK; Paulmurugan R; Chen K; Gheysens O; Rodriguez-Porcel M; Lutz AM; Chen IY; Chen X; Gambhir SS
Radiology; 2008 Feb; 246(2):508-18. PubMed ID: 18180339
[TBL] [Abstract][Full Text] [Related]
5. A novel monoclonal antibody to secreted frizzled-related protein 2 inhibits tumor growth.
Fontenot E; Rossi E; Mumper R; Snyder S; Siamakpour-Reihani S; Ma P; Hilliard E; Bone B; Ketelsen D; Santos C; Patterson C; Klauber-DeMore N
Mol Cancer Ther; 2013 May; 12(5):685-95. PubMed ID: 23604067
[TBL] [Abstract][Full Text] [Related]
6. Targeted Ultrasound Contrast Imaging of Tumor Vasculature With Positively Charged Microbubbles.
Diakova GB; Du Z; Klibanov AL
Invest Radiol; 2020 Nov; 55(11):736-740. PubMed ID: 32569011
[TBL] [Abstract][Full Text] [Related]
7. Six-Transmembrane Epithelial Antigen of the Prostate-1 (STEAP-1)-Targeted Ultrasound Imaging Microbubble Improves Detection of Prostate Cancer In Vivo.
Yuan Y; Liu Y; Zhu XM; Hu J; Zhao CY; Jiang F
J Ultrasound Med; 2019 Feb; 38(2):299-305. PubMed ID: 30027616
[TBL] [Abstract][Full Text] [Related]
8. Rapid Copper-free Click Conjugation to Lipid-Shelled Microbubbles for Ultrasound Molecular Imaging of Murine Bowel Inflammation.
Goncin U; Bernhard W; Curiel L; Geyer CR; Machtaler S
Bioconjug Chem; 2022 May; 33(5):848-857. PubMed ID: 35427123
[TBL] [Abstract][Full Text] [Related]
9. Squamous Cell Carcinoma Xenografts: Use of VEGFR2-targeted Microbubbles for Combined Functional and Molecular US to Monitor Antiangiogenic Therapy Effects.
Baetke SC; Rix A; Tranquart F; Schneider R; Lammers T; Kiessling F; Lederle W
Radiology; 2016 Feb; 278(2):430-40. PubMed ID: 26313618
[TBL] [Abstract][Full Text] [Related]
10. Ultra-Low-Dose Ultrasound Molecular Imaging for the Detection of Angiogenesis in a Mouse Murine Tumor Model: How Little Can We See?
Wang S; Herbst EB; Mauldin FW; Diakova GB; Klibanov AL; Hossack JA
Invest Radiol; 2016 Dec; 51(12):758-766. PubMed ID: 27654582
[TBL] [Abstract][Full Text] [Related]
11. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis.
Pochon S; Tardy I; Bussat P; Bettinger T; Brochot J; von Wronski M; Passantino L; Schneider M
Invest Radiol; 2010 Feb; 45(2):89-95. PubMed ID: 20027118
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55.
Tardy I; Pochon S; Theraulaz M; Emmel P; Passantino L; Tranquart F; Schneider M
Invest Radiol; 2010 Oct; 45(10):573-8. PubMed ID: 20808233
[TBL] [Abstract][Full Text] [Related]
13. A Lipopeptide-Based αvβ₃ Integrin-Targeted Ultrasound Contrast Agent for Molecular Imaging of Tumor Angiogenesis.
Yan F; Xu X; Chen Y; Deng Z; Liu H; Xu J; Zhou J; Tan G; Wu J; Zheng H
Ultrasound Med Biol; 2015 Oct; 41(10):2765-73. PubMed ID: 26166460
[TBL] [Abstract][Full Text] [Related]
14. In vitro characterization and in vivo ultrasound molecular imaging of nucleolin-targeted microbubbles.
Zhang H; Ingham ES; Gagnon MK; Mahakian LM; Liu J; Foiret JL; Willmann JK; Ferrara KW
Biomaterials; 2017 Feb; 118():63-73. PubMed ID: 27940383
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound molecular imaging contrast agent binding to both E- and P-selectin in different species.
Bettinger T; Bussat P; Tardy I; Pochon S; Hyvelin JM; Emmel P; Henrioud S; Biolluz N; Willmann JK; Schneider M; Tranquart F
Invest Radiol; 2012 Sep; 47(9):516-23. PubMed ID: 22814589
[TBL] [Abstract][Full Text] [Related]
16. Microbubbles as ultrasound contrast agents for molecular imaging: preparation and application.
Unnikrishnan S; Klibanov AL
AJR Am J Roentgenol; 2012 Aug; 199(2):292-9. PubMed ID: 22826389
[TBL] [Abstract][Full Text] [Related]
17. Dual-Targeted Microbubbles Specific to Integrin αVβ3 and Vascular Endothelial Growth Factor Receptor 2 for Ultrasonography Evaluation of Tumor Angiogenesis.
Yuan HX; Wang WP; Wen JX; Lin LW; Exner AA; Guan PS; Chen XJ
Ultrasound Med Biol; 2018 Jul; 44(7):1460-1467. PubMed ID: 29706409
[TBL] [Abstract][Full Text] [Related]
18. RGD-Targeted Ultrasound Contrast Agent for Longitudinal Assessment of Hep-2 Tumor Angiogenesis In Vivo.
Hu Q; Wang XY; Kang LK; Wei HM; Xu CM; Wang T; Wen ZH
PLoS One; 2016; 11(2):e0149075. PubMed ID: 26862757
[TBL] [Abstract][Full Text] [Related]
19. Development of antibody-carrying microbubbles based on clinically available ultrasound contrast agent for targeted molecular imaging: a preliminary chemical study.
Otani K; Yamahara K
Mol Imaging Biol; 2011 Apr; 13(2):250-6. PubMed ID: 20512420
[TBL] [Abstract][Full Text] [Related]
20. scVEGF microbubble ultrasound contrast agents: a novel probe for ultrasound molecular imaging of tumor angiogenesis.
Anderson CR; Rychak JJ; Backer M; Backer J; Ley K; Klibanov AL
Invest Radiol; 2010 Oct; 45(10):579-85. PubMed ID: 20733505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
